相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
-20℃
- 克隆性:
单克隆
- 抗体名:
Dopamine Receptor Binding 1 (DRB1) (N-Term) 抗体
- 规格:
0.1ml/0.2ml
Dopamine Receptor Binding 1 (DRB1) (N-Term) 抗体
anti-Dopamine Receptor Binding 1 (DRB1) (N-Term) antibody
抗原
Dopamine Receptor Binding 1 (DRB1)
别名 DRB1, DRw10, HLA-DR1B, HLA-DRB, SS1, Drb1
抗原表位
其他选择 N-Term
适用
其他选择 小鼠, 大鼠, 犬, 牛, 人
宿主
其他选择 兔
克隆类型
多克隆
应用范围
其他选择 Western Blotting (WB)
Pubmed 找到1个引用
规格 100 μg
发货至 中国 (更改)
发货时间 9至12个工作日
产品细节 Dopamine Receptor Binding 1 (DRB1) (N-Term) 抗体
免疫原 Synthetic peptide directed towards the N terminal of human DRB1
序列 MDEAGSSASG GGFRPGVDSL DEPPNSRIFL VISKYTPESV LRERFSPFGD
预测反应 Mouse :100 %, Sumatran orangutan :100 %, Rat :100 %, Human :100 %, Bovine :90 %,
产品特性 This is a rabbit polyclonal antibody against DRB1. It was validated on Western Blot using a cell lysate as a positive control.
纯化方法 Protein A purified
目标详细情况 Dopamine Receptor Binding 1 (DRB1) (N-Term) 抗体
别名 DRB1
背景 DRB1 is RNA-binding protein with binding specificity for poly(C) and may play an important role in neural development.
分子量 36 kDa
基因ID 129831
NCBI登录号 NM_152945, NP_694453
使用细节 Dopamine Receptor Binding 1 (DRB1) (N-Term) 抗体
应用备注 Optimal working dilutions should be determined experimentally by the investigator.
说明
Antigen size: 328 AA
限制 仅限研究用
贮存及处理 Dopamine Receptor Binding 1 (DRB1) (N-Term) 抗体
状态 Lyophilized
溶解方式 Add 100 µL of distilled water.
浓度 1 mg/mL
缓冲液 PBS buffer with 2 % sucrose
注意事项 Avoid repeated freeze-thaw cycles.
储存条件 -20 °C
储存方法 For longer periods of storage, store at -20 °C
yb-3006R phospho-arfaptin 2 (Ser260)磷酸化ADP核糖基化因子结合蛋白2抗体 浓度1mg/ml
yb-3049R Phospho-Aurora B (Thr232) + Aurora C (Thr198)磷酸化有丝分裂激酶B/C抗体 浓度1mg/ml
yb-3001R phospho-Acinus (Ser1180)磷酸化腺泡Acinus蛋白抗体 浓度1mg/ml
yb-3002R phospho-ADRB2 (Ser346)磷酸化肾上腺素能受体β2抗体 浓度1mg/ml
yb-2731R APSAPS抗体 浓度1mg/ml
yb-6020R ACVRL1激活素受体样激酶1抗体 浓度1mg/ml
yb-6018R ACVR1B激活素A受体1B抗体 浓度1mg/ml
yb-3004R phospho-Androgen Receptor (Ser597)磷酸化雄激素受体抗体 浓度1mg/ml
yb-3005R phospho-A Raf (Ser214)磷酸化A-Raf抗体 浓度1mg/ml
yb-6021R ASAH2酰基鞘氨醇脱酰酶2抗体 浓度1mg/ml
yb-6022R ASAM脂肪细胞特异性粘附分子抗体 浓度1mg/ml
yb-11392R AAV5 capsid VP2 protein腺相关病毒5抗体 浓度1mg/ml
yb-3968R AMPK gamma 3腺苷酸活化蛋白激酶γ3抗体 浓度1mg/ml
yb-3967R AMPK beta 2腺苷单磷酸活化蛋白激酶β2抗体 浓度1mg/ml
yb-5173R phospho-APC1 (Ser355)磷酸化细胞周期末期促进复合蛋白APC1抗体 浓度1mg/ml
yb-4090R ANAPC1细胞周期末期促进复合蛋白APC1抗体 浓度1mg/ml
yb-4089R phospho-AKT2 (Ser474)磷酸化蛋白激酶B2抗体 浓度1mg/ml
yb-5165R phospho-APBB1 (Ser175)磷酸化铁蛋白Fe65抗体 浓度1mg/ml
yb-5166R phospho-APBB1 (Ser347)磷酸化铁蛋白Fe65抗体 浓度1mg/ml
yb-5167R phospho-Amyloid Precursor Protein (Thr743)磷酸化APP淀粉样肽前体蛋白抗体 浓度1mg/ml
yb-5168R phospho-Amyloid Precursor Protein (Ser730)磷酸化APP淀粉样肽前体蛋白抗体 浓度1mg/ml
yb-5169R phospho-ATF2 (Ser322)磷酸化活化复制因子2抗体 浓度1mg/ml
yb-5172R phospho-ATF2 (Thr51)磷酸化活化复制因子2抗体 浓度1mg/ml
yb-5174R phospho-APC1 (Ser377)磷酸化细胞周期末期促进复合蛋白APC1抗体 浓度1mg/ml
yb-4091R ASAP1发育分化增强因子1抗体 浓度1mg/ml
yb-5176R phospho-ASAP1 (Tyr782)磷酸化发育分化增强因子1抗体 浓度1mg/ml
yb-5146R AKT3蛋白激酶B3 浓度1mg/ml
yb-5150R Girdin肌动蛋白结合蛋白Girdin抗体 浓度1mg/ml
yb-9028R AKAP2蛋白激酶A2抗体 浓度1mg/ml
yb-2133R AT2R2血管紧张素Ⅱ受体2抗体 浓度1mg/ml
yb-9671R ASH1LASH1蛋白抗体 浓度1mg/ml
yb-11385R AADACL2芳香乙酰胺脱乙酰基酶样蛋白2抗体 浓度1mg/ml
yb-11388R AAMP血管内皮细胞迁移蛋白抗体 浓度1mg/ml
yb-6274R AKR1B10醛糖还原酶相关蛋白质抗体 浓度1mg/ml
yb-6275R AKR1C2胆汁酸结合蛋白DDH2抗体 浓度1mg/ml
yb-5918R ANGPTL3血管生成素样蛋白3抗体 浓度1mg/ml
yb-6276R Acylglycerol Kinase甘油酯激酶线粒体抗体 浓度1mg/ml
yb-6189R phospho-alpha Adducin(Ser726)磷酸化内收蛋白a1抗体 浓度1mg/ml
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Characterization of Dopamine Receptors
are the principal targets of drugs used for the treatment of neuropsychiatric disorders such as schizophrenia and Parkinson's disease. This unit details protocols for radioligand binding assays for various subtypes of dopamine receptor. The scope is limited
Overview of Receptor Allosterism
2010 by John Wiley & Sons, Inc. Keywords: allosteric ternary complex model; bitopic; G protein?coupled receptor; modulator; orthosteric; radioligand binding
Practical Aspects of Radioligand Binding
. Muscarinic responses and binding in a murine neuroblastoma clone (N1E‐115). Mediation of separate responses by high affinity and low affinity agonist‐receptor conformations. Mol. Pharmacol. 27:223‐235.
技术资料暂无技术资料 索取技术资料





